Invention Grant
- Patent Title: Inhibitors of HCV NS5A
- Patent Title (中): HCV NS5A抑制剂
-
Application No.: US13699707Application Date: 2011-05-23
-
Publication No.: US08877707B2Publication Date: 2014-11-04
- Inventor: Min Zhong , Leping Li
- Applicant: Min Zhong , Leping Li
- Applicant Address: US CA San Francisco
- Assignee: Presidio Pharmaceuticals, Inc.
- Current Assignee: Presidio Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: TechLaw LLP
- Agent Sam K. Tahmassebi
- International Application: PCT/US2011/037618 WO 20110523
- International Announcement: WO2011/149856 WO 20111201
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/00 ; A61P1/16 ; C07D403/14 ; C07K5/062 ; C07D401/14 ; C07K5/078 ; C07D403/04 ; C07D401/10 ; C07D409/14 ; C07D471/04 ; C07D413/14 ; C07D405/14 ; C07D417/14 ; A61K31/7056 ; A61K31/4188
Abstract:
Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
Public/Granted literature
- US20130203656A1 INHIBITORS OF HCV NS5A Public/Granted day:2013-08-08
Information query
IPC分类:
